Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators
<strong>Background<br></strong> Several biochemical markers in blood correlate with the magnitude of brain injury and may be used to predict neurological outcome after cardiac arrest. We present a protocol for the evaluation of prognostic accuracy of brain injury markers after card...
| Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Fformat: | Journal article |
| Iaith: | English |
| Cyhoeddwyd: |
Elsevier
2022
|
| _version_ | 1826308169445408768 |
|---|---|
| author | Moseby-Knappe, M Levin, H Blennow, K Ullén, S Zetterberg, H Lilja, G Dankiewicz, J Jakobsen, JC Lagebrant, A Friberg, H Nichol, A Ainschough, K Eastwood, GM Wise, MP Thomas, M Keeble, T Cariou, A Leithner, C Rylander, C Düring, J Bělohlávek, J Grejs, A Borgquist, O Undén, J Simon, M Rolny, V Piehler, A Cronberg, T Nielsen, N |
| author_facet | Moseby-Knappe, M Levin, H Blennow, K Ullén, S Zetterberg, H Lilja, G Dankiewicz, J Jakobsen, JC Lagebrant, A Friberg, H Nichol, A Ainschough, K Eastwood, GM Wise, MP Thomas, M Keeble, T Cariou, A Leithner, C Rylander, C Düring, J Bělohlávek, J Grejs, A Borgquist, O Undén, J Simon, M Rolny, V Piehler, A Cronberg, T Nielsen, N |
| author_sort | Moseby-Knappe, M |
| collection | OXFORD |
| description | <strong>Background<br></strong>
Several biochemical markers in blood correlate with the magnitude of brain injury and may be used to predict neurological outcome after cardiac arrest. We present a protocol for the evaluation of prognostic accuracy of brain injury markers after cardiac arrest. The aim is to define the best predictive marker and to establish clinically useful cut-off levels for routine implementation.
<br><strong>
Methods<br></strong>
Prospective international multicenter trial within the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial in collaboration with Roche Diagnostics International AG. Samples were collected 0, 24, 48, and 72 hours after randomisation (serum) and 0 and 48 hours after randomisation (plasma), and pre-analytically processed at each site before storage in a central biobank. Routine markers neuron-specific enolase (NSE) and S100B, and neurofilament light, total-tau and glial fibrillary acidic protein will be batch analysed using novel Elecsys® electrochemiluminescence immunoassays on a Cobas e601 instrument.
<br><strong>
Results<br></strong>
Statistical analysis will be reported according to the Standards for Reporting Diagnostic accuracy studies (STARD) and will include comparisons for prediction of good versus poor functional outcome at six months post-arrest, by modified Rankin Scale (0–3 vs. 4–6), using logistic regression models and receiver operating characteristics curves, evaluation of mortality at six months according to biomarker levels and establishment of cut-off values for prediction of poor neurological outcome at 95–100% specificities.
<br><strong>
Conclusions<br></strong>
This prospective trial may establish a standard methodology and clinically appropriate cut-off levels for the optimal biomarker of brain injury which predicts poor neurological outcome after cardiac arrest. |
| first_indexed | 2024-03-07T07:13:59Z |
| format | Journal article |
| id | oxford-uuid:85f64d9f-a841-4f52-a38e-3d6d3091b7ed |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:13:59Z |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:85f64d9f-a841-4f52-a38e-3d6d3091b7ed2022-07-27T16:11:35ZBiomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigatorsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:85f64d9f-a841-4f52-a38e-3d6d3091b7edEnglishSymplectic ElementsElsevier2022Moseby-Knappe, MLevin, HBlennow, KUllén, SZetterberg, HLilja, GDankiewicz, JJakobsen, JCLagebrant, AFriberg, HNichol, AAinschough, KEastwood, GMWise, MPThomas, MKeeble, TCariou, ALeithner, CRylander, CDüring, JBělohlávek, JGrejs, ABorgquist, OUndén, JSimon, MRolny, VPiehler, ACronberg, TNielsen, N<strong>Background<br></strong> Several biochemical markers in blood correlate with the magnitude of brain injury and may be used to predict neurological outcome after cardiac arrest. We present a protocol for the evaluation of prognostic accuracy of brain injury markers after cardiac arrest. The aim is to define the best predictive marker and to establish clinically useful cut-off levels for routine implementation. <br><strong> Methods<br></strong> Prospective international multicenter trial within the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial in collaboration with Roche Diagnostics International AG. Samples were collected 0, 24, 48, and 72 hours after randomisation (serum) and 0 and 48 hours after randomisation (plasma), and pre-analytically processed at each site before storage in a central biobank. Routine markers neuron-specific enolase (NSE) and S100B, and neurofilament light, total-tau and glial fibrillary acidic protein will be batch analysed using novel Elecsys® electrochemiluminescence immunoassays on a Cobas e601 instrument. <br><strong> Results<br></strong> Statistical analysis will be reported according to the Standards for Reporting Diagnostic accuracy studies (STARD) and will include comparisons for prediction of good versus poor functional outcome at six months post-arrest, by modified Rankin Scale (0–3 vs. 4–6), using logistic regression models and receiver operating characteristics curves, evaluation of mortality at six months according to biomarker levels and establishment of cut-off values for prediction of poor neurological outcome at 95–100% specificities. <br><strong> Conclusions<br></strong> This prospective trial may establish a standard methodology and clinically appropriate cut-off levels for the optimal biomarker of brain injury which predicts poor neurological outcome after cardiac arrest. |
| spellingShingle | Moseby-Knappe, M Levin, H Blennow, K Ullén, S Zetterberg, H Lilja, G Dankiewicz, J Jakobsen, JC Lagebrant, A Friberg, H Nichol, A Ainschough, K Eastwood, GM Wise, MP Thomas, M Keeble, T Cariou, A Leithner, C Rylander, C Düring, J Bělohlávek, J Grejs, A Borgquist, O Undén, J Simon, M Rolny, V Piehler, A Cronberg, T Nielsen, N Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators |
| title | Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators |
| title_full | Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators |
| title_fullStr | Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators |
| title_full_unstemmed | Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators |
| title_short | Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators |
| title_sort | biomarkers of brain injury after cardiac arrest a statistical analysis plan from the ttm2 trial biobank investigators |
| work_keys_str_mv | AT mosebyknappem biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT levinh biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT blennowk biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT ullens biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT zetterbergh biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT liljag biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT dankiewiczj biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT jakobsenjc biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT lagebranta biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT fribergh biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT nichola biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT ainschoughk biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT eastwoodgm biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT wisemp biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT thomasm biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT keeblet biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT carioua biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT leithnerc biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT rylanderc biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT duringj biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT belohlavekj biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT grejsa biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT borgquisto biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT undenj biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT simonm biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT rolnyv biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT piehlera biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT cronbergt biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators AT nielsenn biomarkersofbraininjuryaftercardiacarrestastatisticalanalysisplanfromthettm2trialbiobankinvestigators |